Prentice Wealth Management’s Biogen BIIB Stock Holding History

Prentice Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-271	Closed	-$55K	–	96
2022 Q2	$55K	Buy	+271	New	+$55.4K	0.06%	67
2021 Q4	–	Sell	-394	Closed	-$111K	–	120
2021 Q3	$111K	Buy	394 +6	+2%	+$1.97K	0.05%	133
2021 Q2	$134K	Sell	388 -93	-19%	-$28.2K	0.07%	124
2021 Q1	$135K	Buy	+481	New	+$130K	0.08%	117

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Prentice Wealth Management's BIIB Position: Q3 2022 in Review

Prentice Wealth Management sold out of Biogen (BIIB) in Q3 2022, closing a stake of 271 shares — an estimated $55K sold.

Prentice Wealth Management first reported a position in BIIB in Q1 2021 and held it in 4 quarters. The position peaked at $135K in Q1 2021. 985 funds tracked by Wall St. Rank hold BIIB as of Q3 2022.

Prentice Wealth Management reported no remaining Biogen position as of Q3 2022 after selling out during the quarter.
Prentice Wealth Management sold 271 Biogen shares in Q3 2022, an estimated $55K.
Prentice Wealth Management first reported a position in Biogen in Q1 2021 and held it in 4 quarters.
Prentice Wealth Management's Biogen position peaked at $135K in Q1 2021.
985 funds tracked by Wall St. Rank held Biogen as of Q3 2022.

Based on Prentice Wealth Management's 13F filing for Q3 2022, filed 19 Oct 2022.